These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

472 related articles for article (PubMed ID: 28378157)

  • 1. Adherence and Persistence Across Antidepressant Therapeutic Classes: A Retrospective Claims Analysis Among Insured US Patients with Major Depressive Disorder (MDD).
    Keyloun KR; Hansen RN; Hepp Z; Gillard P; Thase ME; Devine EB
    CNS Drugs; 2017 May; 31(5):421-432. PubMed ID: 28378157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacy and medical costs associated with switching between venlafaxine and SSRI antidepressant therapy for the treatment of major depressive disorder.
    Khandker RK; Kruzikas DT; McLaughlin TP
    J Manag Care Pharm; 2008 Jun; 14(5):426-41. PubMed ID: 18597572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discontinuation rates and health care costs in adult patients starting generic versus brand SSRI or SNRI antidepressants in commercial health plans.
    Vlahiotis A; Devine ST; Eichholz J; Kautzner A
    J Manag Care Pharm; 2011 Mar; 17(2):123-32. PubMed ID: 21348545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Higher costs and therapeutic factors associated with adherence to NCQA HEDIS antidepressant medication management measures: analysis of administrative claims.
    Robinson RL; Long SR; Chang S; Able S; Baser O; Obenchain RL; Swindle RW
    J Manag Care Pharm; 2006; 12(1):43-54. PubMed ID: 16420107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Health care resource utilization and costs associated with nonadherence and nonpersistence to antidepressants in major depressive disorder.
    Ta JT; Sullivan SD; Tung A; Oliveri D; Gillard P; Devine B
    J Manag Care Spec Pharm; 2021 Feb; 27(2):223-239. PubMed ID: 33506730
    [No Abstract]   [Full Text] [Related]  

  • 6. Differences in medication adherence and healthcare resource utilization patterns: older versus newer antidepressant agents in patients with depression and/or anxiety disorders.
    Sheehan DV; Keene MS; Eaddy M; Krulewicz S; Kraus JE; Carpenter DJ
    CNS Drugs; 2008; 22(11):963-73. PubMed ID: 18840035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The association of race, comorbid anxiety, and antidepressant adherence among Medicaid enrollees with major depressive disorder.
    Wu CH; Erickson SR; Piette JD; Balkrishnan R
    Res Social Adm Pharm; 2012; 8(3):193-205. PubMed ID: 21955808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medication Adherence and Persistence in Patients with Severe Major Depressive Disorder with Psychotic Features: Antidepressant and Second-Generation Antipsychotic Therapy Versus Antidepressant Monotherapy.
    Kim-Romo DN; Rascati KL; Richards KM; Ford KC; Wilson JP; Beretvas SN
    J Manag Care Spec Pharm; 2016 May; 22(5):588-96. PubMed ID: 27123919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of adherence to antidepressants on healthcare outcomes and costs among patients with type 2 diabetes and comorbid major depressive disorder.
    Vega C; Becker RV; Mucha L; Lorenz BH; Eaddy MT; Ogbonnaya AO
    Curr Med Res Opin; 2017 Oct; 33(10):1879-1889. PubMed ID: 28644095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment adherence and persistence with duloxetine, venlafaxine XR, and escitalopram among patients with major depressive disorder and chronic pain-related diseases.
    Wang J; Liu X; Mullins CD
    Curr Med Res Opin; 2011 Jul; 27(7):1303-13. PubMed ID: 21561393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Real-world treatment patterns of patients with major depressive disorder treated with Auvelity in the United States.
    Muzyk A; Syed FZ; Zhou H; Cong J; Tabuteau H; Zhao Y
    J Med Econ; 2024; 27(1):1003-1010. PubMed ID: 39042111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The association between antidepressant dosage titration and medication adherence among patients with depression.
    Wu CH; Farley JF; Gaynes BN
    Depress Anxiety; 2012 Jun; 29(6):506-14. PubMed ID: 22553149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of depression medications on oral antidiabetic drug adherence in patients with diabetes and depression.
    Xing S; Calip GS; Leow AD; Kim S; Schumock GT; Touchette DR; Lee TA
    J Diabetes Complications; 2018 May; 32(5):492-500. PubMed ID: 29544744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of treatment patterns and persistence on branded and generic medications in major depressive disorder using retrospective claims data.
    Solem CT; Shelbaya A; Wan Y; Deshpande CG; Alvir J; Pappadopulos E
    Neuropsychiatr Dis Treat; 2016; 12():2755-2764. PubMed ID: 27822048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rates of 5 common antidepressant side effects among new adult and adolescent cases of depression: a retrospective US claims study.
    Anderson HD; Pace WD; Libby AM; West DR; Valuck RJ
    Clin Ther; 2012 Jan; 34(1):113-23. PubMed ID: 22177545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antidepressant treatment and risk of suicide attempt by adolescents with major depressive disorder: a propensity-adjusted retrospective cohort study.
    Valuck RJ; Libby AM; Sills MR; Giese AA; Allen RR
    CNS Drugs; 2004; 18(15):1119-32. PubMed ID: 15581382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early discontinuation and suboptimal dosing of duloxetine treatment in patients with major depressive disorder: analysis from a US third-party payer perspective.
    Cui Z; Faries DE; Gelwicks S; Novick D; Liu X
    J Med Econ; 2012; 15(1):134-44. PubMed ID: 22014076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medication Adherence, Health Care Utilization, and Costs in Patients With Major Depressive Disorder Initiating Adjunctive Atypical Antipsychotic Treatment.
    Broder MS; Greene M; Yan T; Chang E; Hartry A; Yermilov I
    Clin Ther; 2019 Feb; 41(2):221-232. PubMed ID: 30616973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Earlier Versus Later Augmentation with an Antipsychotic Medication in Patients with Major Depressive Disorder Demonstrating Inadequate Efficacy in Response to Antidepressants: A Retrospective Analysis of US Claims Data.
    Yermilov I; Greene M; Chang E; Hartry A; Yan T; Broder MS
    Adv Ther; 2018 Dec; 35(12):2138-2151. PubMed ID: 30456519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparing adherence and persistence across 6 chronic medication classes.
    Yeaw J; Benner JS; Walt JG; Sian S; Smith DB
    J Manag Care Pharm; 2009; 15(9):728-40. PubMed ID: 19954264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.